NDC 25021-796 – Glycopyrrolate
Glycopyrrolate .2 mg/mL · Injection, Solution · Intramuscular, Intravenous
Product NDC25021-796
Product details
- Brand name
- Glycopyrrolate
- Generic name
- Glycopyrrolate
- Labeler
- Sagent Pharmaceuticals
- Dosage form
- Injection, Solution
- Route
- Intramuscular, Intravenous
- Marketing category
- ANDA · ANDA210083
- Marketed since
- October 15, 2024
- Listing expires
- December 31, 2027
- Pharmacologic class
- Anticholinergic; Cholinergic Muscarinic Antagonist
Active ingredients
- Glycopyrrolate .2 mg/mL
Uses, dosage, side effects and warnings for Glycopyrrolate →
Package NDC codes (3)
| Package NDC | Description | Since |
|---|---|---|
| 25021-796-01 | 10 VIAL in 1 CARTON (25021-796-01) / 1 mL in 1 VIAL | Oct 15, 2024 |
| 25021-796-02 | 10 VIAL in 1 CARTON (25021-796-02) / 2 mL in 1 VIAL | Nov 15, 2024 |
| 25021-796-05 | 10 VIAL in 1 CARTON (25021-796-05) / 5 mL in 1 VIAL | Nov 15, 2024 |
Other Glycopyrrolate products
- 0517-4620 Glycopyrrolate .2 mg/mL · Injection, Solution · American Regent, Inc.
- 0517-4605 Glycopyrrolate .2 mg/mL · Injection, Solution · American Regent, Inc.
- 0517-4602 Glycopyrrolate .2 mg/mL · Injection, Solution · American Regent, Inc.
- 0517-4601 Glycopyrrolate .2 mg/mL · Injection, Solution · American Regent, Inc.
- 70121-1698 Glycopyrrolate .2 mg/mL · Injection, Solution · Amneal Pharmaceuticals LLC
- 70121-1699 Glycopyrrolate .2 mg/mL · Injection, Solution · Amneal Pharmaceuticals LLC
- 55150-295 Glycopyrrolate .2 mg/mL · Injection, Solution · AuroMedics Pharma LLC
- 55150-294 Glycopyrrolate .2 mg/mL · Injection, Solution · AuroMedics Pharma LLC
- 55150-293 Glycopyrrolate .2 mg/mL · Injection, Solution · AuroMedics Pharma LLC
- 55150-292 Glycopyrrolate .2 mg/mL · Injection, Solution · AuroMedics Pharma LLC
- 72572-226 Glycopyrrolate .2 mg/mL · Injection, Solution · Civica, Inc.
- 63323-578 Glycopyrrolate .2 mg/mL · Injection, Solution · Fresenius Kabi USA, LLC